4//SEC Filing
Lettmann Jason 4
Accession 0001193125-25-207432
CIK 0001810182other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:23 PM ET
Size
6.6 KB
Accession
0001193125-25-207432
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2025-09-17$1.08/sh+71,163$76,892→ 305,121 total - Purchase
Common Stock
2025-09-16$1.07/sh+21,070$22,461→ 233,958 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive.
Documents
Issuer
ALX ONCOLOGY HOLDINGS INC
CIK 0001810182
Entity typeother
Related Parties
1- filerCIK 0001688269
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:23 PM ET
- Size
- 6.6 KB